AACR Cancer Progress Report 2025
Screening for Early Detection: Using evidence-based guidelines to screen for cancer can help find aberrations at the earliest possible detectable phase of cancer development and progression.
Read the Report
Screening for Early Detection: Using evidence-based guidelines to screen for cancer can help find aberrations at the earliest possible detectable phase of cancer development and progression.
Read the Report
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreIn this week’s episode of Believe in Progress, Katie Rabinowitz, an attorney, marathoner, and metastatic breast cancer survivor, talks about resilience, advocacy, and her commitment to living well with cancer.
Listen and SubscribeNearly 81,000 people in the United States were diagnosed with kidney cancer last year. Learn about this type of cancer, including treatment options. March is Kidney Cancer Awareness Month.
Learn MoreResearchers are shedding light on the multifaceted ways that extrachromosomal DNA impacts cancer development and resistance to targeted therapies.
Learn MoreRead about recent U.S. Food and Drug Administration approvals of products for cancer prevention, diagnosis, and treatment.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowAccess to AACR Annual Meeting 2026 housing reservations is now available to all attendees. Book by March 25 for the best rates.
The AACR Pediatric Cancer Progress Report 2025 highlights the remarkable progress against childhood cancers driven by discoveries across the basic, translational, clinical, and population sciences.
Learn MoreThe AACR and its more than 61,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreThe AACR Cancer Progress Report 2025 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2023
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2024, to June 30, 2025
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 61,000 members worldwide drive progress against cancer.
Donate Now
